| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.552 | 0.01 | 0.552 | MAP kinase kinase 6 inhibitor | 0.506 0.017 DBMET01888 0.506 0.017 DBMET01890 0.532 0.012 DBMET01892 0.433 0.041 DBMET01893 0.323 0.115 DBMET01889 0.323 0.115 DBMET01891 0.416 0.05 DBMET01894 0.34 0.101 DBMET01895 | ||
| 0.456 | 0.007 | 0.456 | 5 Hydroxytryptamine 2 antagonist | 0.234 0.024 DBMET01888 0.234 0.024 DBMET01890 0.446 0.008 DBMET01892 0.373 0.011 DBMET01893 | ||
| 0.479 | 0.044 | 0.479 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.349 0.152 DBMET01888 0.349 0.152 DBMET01890 0.359 0.141 DBMET01892 0.27 0.256 DBMET01893 0.289 0.228 DBMET01894 | ||
| 0.426 | 0.01 | 0.427 | 5 Hydroxytryptamine antagonist | 0.176 0.04 DBMET01888 0.176 0.04 DBMET01890 0.427 0.01 DBMET01892 0.248 0.025 DBMET01893 0.094 0.085 DBMET01894 | DBMET01892 | |
| 0.407 | 0.007 | 0.407 | 5 Hydroxytryptamine 2A antagonist | 0.195 0.02 DBMET01888 0.195 0.02 DBMET01890 0.39 0.007 DBMET01892 0.33 0.01 DBMET01893 | ||
| 0.398 | 0.009 | 0.398 | 5 Hydroxytryptamine 2B antagonist | 0.173 0.032 DBMET01888 0.173 0.032 DBMET01890 0.395 0.009 DBMET01892 0.239 0.02 DBMET01893 | ||
| 0.392 | 0.008 | 0.392 | Dopamine antagonist | 0.204 0.018 DBMET01888 0.204 0.018 DBMET01890 0.195 0.019 DBMET01892 0.268 0.013 DBMET01893 | ||
| 0.402 | 0.021 | 0.402 | Anticonvulsant | 0.301 0.04 DBMET01888 0.301 0.04 DBMET01890 0.313 0.037 DBMET01892 0.149 0.13 DBMET01895 | ||
| 0.371 | 0.008 | 0.371 | Dopamine D2 antagonist | 0.199 0.017 DBMET01888 0.199 0.017 DBMET01890 0.181 0.019 DBMET01892 0.173 0.019 DBMET01893 | ||
| 0.36 | 0.002 | 0.36 | 5 Hydroxytryptamine 3B antagonist | 0.108 0.004 DBMET01888 0.108 0.004 DBMET01890 0.263 0.003 DBMET01892 0.064 0.01 DBMET01893 | ||
| 0.412 | 0.073 | 0.47 | Calcium channel L-type activator | 0.375 0.099 DBMET01888 0.375 0.099 DBMET01890 0.47 0.041 DBMET01892 0.393 0.086 DBMET01893 0.271 0.184 DBMET01889 0.271 0.184 DBMET01891 0.433 0.06 DBMET01894 0.458 0.047 DBMET01895 | DBMET01892 | |
| 0.332 | 0.014 | 0.335 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.282 0.035 DBMET01888 0.282 0.035 DBMET01890 0.335 0.014 DBMET01892 0.256 0.058 DBMET01893 0.2 0.166 DBMET01889 0.2 0.166 DBMET01891 0.258 0.056 DBMET01894 0.209 0.14 DBMET01895 | DBMET01892 | |
| 0.311 | 0.043 | 0.311 | Potassium channel blocker | 0.182 0.105 DBMET01888 0.182 0.105 DBMET01890 0.268 0.058 DBMET01892 0.247 0.068 DBMET01893 | ||
| 0.27 | 0.008 | 0.27 | Dopamine D4 antagonist | 0.076 0.034 DBMET01888 0.076 0.034 DBMET01890 0.104 0.025 DBMET01892 0.071 0.036 DBMET01893 | ||
| 0.308 | 0.047 | 0.308 | Potassium channel (Voltage-sensitive) blocker | 0.191 0.102 DBMET01888 0.191 0.102 DBMET01890 0.28 0.056 DBMET01892 0.266 0.061 DBMET01893 | ||
| 0.266 | 0.011 | 0.307 | 5 Hydroxytryptamine 2C antagonist | 0.1 0.045 DBMET01888 0.1 0.045 DBMET01890 0.307 0.009 DBMET01892 0.212 0.016 DBMET01893 0.079 0.062 DBMET01894 | DBMET01892 | |
| 0.374 | 0.128 | 0.524 | Caspase 9 stimulant | 0.464 0.076 DBMET01888 0.464 0.076 DBMET01890 0.461 0.077 DBMET01892 0.524 0.051 DBMET01889 0.524 0.051 DBMET01891 0.323 0.17 DBMET01894 0.306 0.188 DBMET01895 | DBMET01891 | |
| 0.25 | 0.005 | 0.259 | 5 Hydroxytryptamine 3 antagonist | 0.089 0.02 DBMET01888 0.089 0.02 DBMET01890 0.259 0.004 DBMET01892 0.091 0.02 DBMET01893 | DBMET01892 | |
| 0.266 | 0.025 | 0.278 | Cholinergic | 0.203 0.045 DBMET01888 0.203 0.045 DBMET01890 0.278 0.022 DBMET01892 0.272 0.024 DBMET01893 0.274 0.023 DBMET01894 0.15 0.077 DBMET01895 | DBMET01892 | |
| 0.241 | 0.004 | 0.435 | 5 Hydroxytryptamine 2 agonist | 0.126 0.006 DBMET01888 0.126 0.006 DBMET01890 0.435 0.003 DBMET01892 0.077 0.016 DBMET01893 0.115 0.007 DBMET01894 | DBMET01892 | |
| 0.279 | 0.043 | 0.279 | EphB2 antagonist | 0.252 0.056 DBMET01888 0.252 0.056 DBMET01890 0.273 0.045 DBMET01892 0.147 0.132 DBMET01893 0.207 0.083 DBMET01894 0.181 0.102 DBMET01895 | ||
| 0.235 | 0.004 | 0.337 | 5 Hydroxytryptamine 2A agonist | 0.144 0.005 DBMET01888 0.144 0.005 DBMET01890 0.337 0.003 DBMET01892 0.086 0.023 DBMET01893 0.1 0.014 DBMET01894 | DBMET01892 | |
| 0.245 | 0.015 | 0.308 | Butyrylcholinesterase inhibitor | 0.158 0.031 DBMET01888 0.158 0.031 DBMET01890 0.219 0.019 DBMET01892 0.168 0.028 DBMET01893 0.308 0.01 DBMET01894 0.145 0.036 DBMET01895 | DBMET01894 | |
| 0.31 | 0.082 | 0.369 | Calcium channel activator | 0.344 0.054 DBMET01888 0.344 0.054 DBMET01890 0.369 0.039 DBMET01892 | DBMET01892 | |
| 0.28 | 0.055 | 0.28 | HERG channel blocker | 0.153 0.128 DBMET01888 0.153 0.128 DBMET01890 0.273 0.057 DBMET01892 0.273 0.057 DBMET01893 | ||
| 0.24 | 0.015 | 0.24 | Antihistaminic | 0.103 0.053 DBMET01888 0.103 0.053 DBMET01890 0.174 0.026 DBMET01892 0.183 0.024 DBMET01893 | ||
| 0.235 | 0.012 | 0.403 | 5 Hydroxytryptamine agonist | 0.099 0.034 DBMET01888 0.099 0.034 DBMET01890 0.403 0.005 DBMET01892 0.156 0.02 DBMET01893 0.085 0.039 DBMET01894 | DBMET01892 | |
| 0.236 | 0.015 | 0.236 | Histamine antagonist | 0.091 0.054 DBMET01888 0.091 0.054 DBMET01890 0.168 0.025 DBMET01892 0.179 0.023 DBMET01893 | ||
| 0.231 | 0.014 | 0.283 | MAP kinase 13 inhibitor | 0.157 0.033 DBMET01888 0.157 0.033 DBMET01890 0.283 0.007 DBMET01892 0.138 0.042 DBMET01893 0.227 0.014 DBMET01894 0.142 0.04 DBMET01895 | DBMET01892 | |
| 0.239 | 0.023 | 0.26 | Acetylcholinesterase inhibitor | 0.179 0.04 DBMET01888 0.179 0.04 DBMET01890 0.216 0.029 DBMET01892 0.204 0.032 DBMET01893 0.26 0.019 DBMET01894 0.157 0.051 DBMET01895 | DBMET01894 | |
| 0.236 | 0.024 | 0.236 | Ribosomal protein S6 kinase inhibitor | 0.162 0.056 DBMET01888 0.162 0.056 DBMET01890 0.168 0.053 DBMET01892 0.121 0.089 DBMET01894 | ||
| 0.213 | 0.01 | 0.213 | Dopamine D3 antagonist | 0.078 0.033 DBMET01888 0.078 0.033 DBMET01890 0.098 0.025 DBMET01892 0.151 0.015 DBMET01893 | ||
| 0.225 | 0.033 | 0.225 | Acetylcholine M1 receptor antagonist | 0.21 0.038 DBMET01888 0.21 0.038 DBMET01890 0.162 0.064 DBMET01892 0.154 0.071 DBMET01893 | ||
| 0.22 | 0.028 | 0.22 | Toll-Like receptor 9 antagonist | 0.19 0.04 DBMET01892 | ||
| 0.226 | 0.035 | 0.448 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.19 0.044 DBMET01888 0.19 0.044 DBMET01890 0.203 0.041 DBMET01892 0.448 0.005 DBMET01893 0.106 0.095 DBMET01894 | DBMET01893 | |
| 0.203 | 0.014 | 0.212 | MAP3K9 inhibitor | 0.183 0.024 DBMET01888 0.183 0.024 DBMET01890 0.212 0.011 DBMET01892 0.174 0.031 DBMET01893 0.127 0.099 DBMET01889 0.127 0.099 DBMET01891 0.19 0.02 DBMET01894 0.182 0.025 DBMET01895 | DBMET01892 | |
| 0.197 | 0.015 | 0.222 | MAP kinase kinase 4 inhibitor | 0.213 0.01 DBMET01888 0.213 0.01 DBMET01890 0.222 0.008 DBMET01892 0.172 0.031 DBMET01893 0.144 0.075 DBMET01889 0.144 0.075 DBMET01891 0.184 0.021 DBMET01894 0.172 0.031 DBMET01895 | DBMET01892 | |
| 0.244 | 0.063 | 0.276 | MAP-kinase-activated kinase 5 inhibitor | 0.213 0.088 DBMET01888 0.213 0.088 DBMET01890 0.276 0.044 DBMET01892 0.166 0.156 DBMET01894 | DBMET01892 | |
| 0.206 | 0.027 | 0.221 | Alpha adrenoreceptor antagonist | 0.097 0.058 DBMET01888 0.097 0.058 DBMET01890 0.221 0.024 DBMET01892 0.197 0.028 DBMET01893 | DBMET01892 | |
| 0.256 | 0.086 | 0.423 | 5 Hydroxytryptamine release stimulant | 0.21 0.113 DBMET01888 0.21 0.113 DBMET01890 0.423 0.041 DBMET01892 0.213 0.111 DBMET01889 0.213 0.111 DBMET01891 0.186 0.134 DBMET01894 | DBMET01892 | |
| 0.189 | 0.02 | 0.194 | GABA receptor agonist | 0.155 0.033 DBMET01888 0.155 0.033 DBMET01890 0.171 0.026 DBMET01892 0.194 0.019 DBMET01893 0.094 0.085 DBMET01894 | DBMET01893 | |
| 0.168 | 0.004 | 0.168 | 5 Hydroxytryptamine 3A antagonist | 0.086 0.026 DBMET01888 0.086 0.026 DBMET01890 0.16 0.005 DBMET01892 | ||
| 0.227 | 0.065 | 0.356 | MAP kinase kinase 2 inhibitor | 0.222 0.068 DBMET01888 0.222 0.068 DBMET01890 0.281 0.042 DBMET01892 0.356 0.019 DBMET01894 | DBMET01894 | |
| 0.26 | 0.099 | 0.302 | Nootropic | 0.21 0.145 DBMET01888 0.21 0.145 DBMET01890 0.302 0.073 DBMET01892 0.19 0.172 DBMET01893 0.243 0.114 DBMET01894 | DBMET01892 | |
| 0.198 | 0.038 | 0.259 | Activin receptor-like kinase 2 inhibitor | 0.131 0.083 DBMET01888 0.131 0.083 DBMET01890 0.259 0.019 DBMET01892 | DBMET01892 | |
| 0.271 | 0.113 | 0.329 | Vasodilator, peripheral | 0.329 0.083 DBMET01888 0.329 0.083 DBMET01890 0.264 0.117 DBMET01892 0.325 0.085 DBMET01889 0.325 0.085 DBMET01891 | DBMET01890 | |
| 0.176 | 0.018 | 0.219 | Alpha 2a adrenoreceptor antagonist | 0.08 0.049 DBMET01888 0.08 0.049 DBMET01890 0.219 0.012 DBMET01892 0.117 0.03 DBMET01893 | DBMET01892 | |
| 0.179 | 0.022 | 0.255 | 5 Hydroxytryptamine 3A agonist | 0.255 0.005 DBMET01892 0.141 0.041 DBMET01894 | DBMET01892 | |
| 0.241 | 0.085 | 0.473 | Interleukin agonist | 0.318 0.04 DBMET01888 0.318 0.04 DBMET01890 0.177 0.143 DBMET01892 0.473 0.011 DBMET01889 0.473 0.011 DBMET01891 | DBMET01891 | |
| 0.169 | 0.014 | 0.169 | Glutamate receptor agonist | 0.09 0.045 DBMET01888 0.09 0.045 DBMET01890 0.15 0.017 DBMET01892 0.071 0.062 DBMET01894 0.098 0.038 DBMET01895 | ||
| 0.251 | 0.099 | 0.251 | Ca(v)3.3 blocker | 0.208 0.175 DBMET01894 | ||
| 0.168 | 0.017 | 0.227 | Hedgehog signaling inhibitor | 0.161 0.02 DBMET01888 0.161 0.02 DBMET01890 0.227 0.008 DBMET01892 0.092 0.08 DBMET01893 | DBMET01892 | |
| 0.164 | 0.013 | 0.164 | Dopamine D1 antagonist | 0.083 0.031 DBMET01888 0.083 0.031 DBMET01890 0.102 0.024 DBMET01892 0.105 0.024 DBMET01893 | ||
| 0.168 | 0.018 | 0.168 | Multidrug resistance-associated protein 1 inhibitor | 0.133 0.036 DBMET01888 0.133 0.036 DBMET01890 0.124 0.044 DBMET01892 0.097 0.084 DBMET01893 0.168 0.018 DBMET01889 0.168 0.018 DBMET01891 | ||
| 0.228 | 0.082 | 0.382 | Antiamyloidogenic | 0.192 0.105 DBMET01888 0.192 0.105 DBMET01890 0.223 0.085 DBMET01892 0.18 0.114 DBMET01893 0.353 0.038 DBMET01889 0.353 0.038 DBMET01891 0.382 0.032 DBMET01894 0.291 0.055 DBMET01895 | DBMET01894 | |
| 0.169 | 0.023 | 0.213 | Alpha 2 adrenoreceptor antagonist | 0.106 0.044 DBMET01888 0.106 0.044 DBMET01890 0.213 0.016 DBMET01892 0.1 0.048 DBMET01893 | DBMET01892 | |
| 0.165 | 0.02 | 0.284 | Protein kinase C mu inhibitor | 0.153 0.025 DBMET01888 0.153 0.025 DBMET01890 0.284 0.005 DBMET01892 0.094 0.063 DBMET01893 0.283 0.005 DBMET01894 0.141 0.03 DBMET01895 | DBMET01892 | |
| 0.164 | 0.021 | 0.182 | Histamine H1 receptor antagonist | 0.078 0.059 DBMET01888 0.078 0.059 DBMET01890 0.103 0.039 DBMET01892 0.182 0.017 DBMET01893 | DBMET01893 | |
| 0.164 | 0.023 | 0.229 | Activin receptor-like kinase 4 inhibitor | 0.122 0.05 DBMET01888 0.122 0.05 DBMET01890 0.229 0.009 DBMET01892 0.111 0.066 DBMET01893 0.108 0.07 DBMET01894 | DBMET01892 | |
| 0.158 | 0.018 | 0.158 | Transcription factor STAT6 inhibitor | 0.146 0.026 DBMET01888 0.146 0.026 DBMET01890 0.143 0.029 DBMET01892 0.111 0.078 DBMET01894 | ||
| 0.149 | 0.01 | 0.149 | Acetylcholine M4 receptor antagonist | 0.094 0.033 DBMET01888 0.094 0.033 DBMET01890 0.112 0.021 DBMET01892 0.116 0.019 DBMET01893 | ||
| 0.288 | 0.151 | 0.288 | Analgesic | 0.275 0.161 DBMET01888 0.275 0.161 DBMET01890 0.274 0.162 DBMET01892 | ||
| 0.159 | 0.022 | 0.159 | 5 Hydroxytryptamine 1 antagonist | 0.154 0.023 DBMET01892 0.104 0.036 DBMET01893 | ||
| 0.163 | 0.027 | 0.177 | Alpha 1 adrenoreceptor antagonist | 0.175 0.025 DBMET01892 0.177 0.024 DBMET01893 | DBMET01893 | |
| 0.165 | 0.033 | 0.2 | Alpha 2b adrenoreceptor antagonist | 0.2 0.024 DBMET01892 0.15 0.039 DBMET01893 | DBMET01892 | |
| 0.214 | 0.084 | 0.346 | Cyclic AMP phosphodiesterase inhibitor | 0.227 0.076 DBMET01888 0.227 0.076 DBMET01890 0.208 0.088 DBMET01892 0.346 0.027 DBMET01889 0.346 0.027 DBMET01891 | DBMET01891 | |
| 0.146 | 0.016 | 0.146 | GABA A receptor agonist | 0.114 0.027 DBMET01888 0.114 0.027 DBMET01890 0.128 0.021 DBMET01892 | ||
| 0.179 | 0.05 | 0.225 | Tyrosine-protein kinase receptor antagonist | 0.164 0.057 DBMET01888 0.164 0.057 DBMET01890 0.225 0.032 DBMET01892 0.116 0.09 DBMET01894 | DBMET01892 | |
| 0.138 | 0.012 | 0.148 | Protein kinase B alpha inhibitor | 0.095 0.032 DBMET01888 0.095 0.032 DBMET01890 0.148 0.009 DBMET01892 0.063 0.057 DBMET01893 | DBMET01892 | |
| 0.162 | 0.041 | 0.162 | Nav1.3 sodium channel blocker | 0.105 0.092 DBMET01892 | ||
| 0.197 | 0.076 | 0.197 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.167 0.11 DBMET01888 0.167 0.11 DBMET01890 0.148 0.136 DBMET01892 0.159 0.12 DBMET01894 | ||
| 0.157 | 0.036 | 0.172 | Beta amyloid protein antagonist | 0.125 0.063 DBMET01888 0.125 0.063 DBMET01890 0.162 0.033 DBMET01892 0.172 0.027 DBMET01889 0.172 0.027 DBMET01891 0.101 0.089 DBMET01894 0.108 0.079 DBMET01895 | DBMET01891 | |
| 0.162 | 0.042 | 0.162 | Nav1.6 sodium channel blocker | 0.13 0.08 DBMET01892 | ||
| 0.15 | 0.032 | 0.15 | Alpha 2c adrenoreceptor antagonist | 0.097 0.069 DBMET01888 0.097 0.069 DBMET01890 0.142 0.036 DBMET01892 0.122 0.048 DBMET01893 | ||
| 0.161 | 0.044 | 0.161 | Sphingosine 1-phosphate receptor 5 antagonist | 0.139 0.082 DBMET01892 0.141 0.078 DBMET01894 0.161 0.045 DBMET01895 | ||
| 0.131 | 0.015 | 0.153 | 5 Hydroxytryptamine 1B antagonist | 0.153 0.012 DBMET01892 | DBMET01892 | |
| 0.136 | 0.022 | 0.136 | 5 Hydroxytryptamine 1A antagonist | 0.123 0.025 DBMET01892 0.101 0.032 DBMET01893 | ||
| 0.132 | 0.02 | 0.132 | 5 Hydroxytryptamine 7 antagonist | 0.06 0.045 DBMET01888 0.06 0.045 DBMET01890 0.126 0.021 DBMET01892 | ||
| 0.12 | 0.008 | 0.12 | Dopamine D5 antagonist | 0.067 0.016 DBMET01888 0.067 0.016 DBMET01890 0.047 0.027 DBMET01892 0.085 0.011 DBMET01893 | ||
| 0.121 | 0.01 | 0.142 | Transforming growth factor beta 3 antagonist | 0.09 0.038 DBMET01888 0.09 0.038 DBMET01890 0.142 0.005 DBMET01892 0.127 0.008 DBMET01893 0.088 0.043 DBMET01894 | DBMET01892 | |
| 0.141 | 0.031 | 0.141 | Insulin receptor antagonist | 0.095 0.068 DBMET01888 0.095 0.068 DBMET01890 0.1 0.061 DBMET01892 | ||
| 0.15 | 0.041 | 0.227 | MAP kinase 12 inhibitor | 0.112 0.08 DBMET01888 0.112 0.08 DBMET01890 0.205 0.021 DBMET01892 0.227 0.015 DBMET01894 0.137 0.052 DBMET01895 | DBMET01894 | |
| 0.114 | 0.006 | 0.114 | Glutamate (mGluR group I) agonist | 0.051 0.03 DBMET01888 0.051 0.03 DBMET01890 0.08 0.012 DBMET01892 | ||
| 0.158 | 0.05 | 0.16 | Toll-Like receptor antagonist | 0.16 0.049 DBMET01892 0.108 0.107 DBMET01894 | DBMET01892 | |
| 0.133 | 0.026 | 0.16 | Alpha 1a adrenoreceptor antagonist | 0.16 0.022 DBMET01892 0.153 0.023 DBMET01893 | DBMET01892 | |
| 0.108 | 0.006 | 0.108 | Glutamate (mGluR5) agonist | 0.051 0.025 DBMET01888 0.051 0.025 DBMET01890 0.077 0.011 DBMET01892 0.043 0.036 DBMET01893 | ||
| 0.155 | 0.055 | 0.302 | Phosphodiesterase inhibitor | 0.154 0.055 DBMET01888 0.154 0.055 DBMET01890 0.146 0.061 DBMET01892 0.302 0.014 DBMET01893 | DBMET01893 | |
| 0.119 | 0.019 | 0.119 | Phosphodiesterase 5A inhibitor | 0.091 0.031 DBMET01888 0.091 0.031 DBMET01890 0.071 0.048 DBMET01892 0.075 0.044 DBMET01893 | ||
| 0.116 | 0.017 | 0.122 | Protein kinase B beta inhibitor | 0.085 0.037 DBMET01888 0.085 0.037 DBMET01890 0.122 0.014 DBMET01892 0.068 0.06 DBMET01893 | DBMET01892 | |
| 0.118 | 0.019 | 0.118 | Phosphodiesterase V inhibitor | 0.09 0.033 DBMET01888 0.09 0.033 DBMET01890 0.073 0.048 DBMET01892 0.075 0.046 DBMET01893 | ||
| 0.115 | 0.018 | 0.115 | 5 Hydroxytryptamine 1 agonist | 0.114 0.018 DBMET01892 0.049 0.038 DBMET01893 | ||
| 0.108 | 0.014 | 0.108 | 5 Hydroxytryptamine 1A agonist | 0.042 0.035 DBMET01888 0.042 0.035 DBMET01890 0.091 0.017 DBMET01892 0.067 0.023 DBMET01893 | ||
| 0.117 | 0.025 | 0.158 | 5 Hydroxytryptamine 1F antagonist | 0.158 0.015 DBMET01892 0.084 0.04 DBMET01894 | DBMET01892 | |
| 0.157 | 0.066 | 0.269 | NOS3 expression enhancer | 0.198 0.041 DBMET01888 0.198 0.041 DBMET01890 0.193 0.044 DBMET01892 0.123 0.109 DBMET01893 0.269 0.023 DBMET01889 0.269 0.023 DBMET01891 0.135 0.09 DBMET01894 0.17 0.056 DBMET01895 | DBMET01891 | |
| 0.104 | 0.014 | 0.153 | 5 Hydroxytryptamine 6 antagonist | 0.153 0.006 DBMET01892 0.064 0.033 DBMET01894 | DBMET01892 | |
| 0.118 | 0.027 | 0.131 | Phosphodiesterase 6D inhibitor | 0.105 0.044 DBMET01888 0.105 0.044 DBMET01890 0.096 0.061 DBMET01892 0.131 0.017 DBMET01889 0.131 0.017 DBMET01891 | DBMET01891 | |
| 0.184 | 0.094 | 0.235 | Neurotrophic factor enhancer | 0.235 0.048 DBMET01888 0.235 0.048 DBMET01890 0.182 0.095 DBMET01889 0.182 0.095 DBMET01891 | DBMET01890 | |
| 0.097 | 0.008 | 0.097 | 5 Hydroxytryptamine 7 agonist | 0.059 0.033 DBMET01888 0.059 0.033 DBMET01890 0.067 0.022 DBMET01892 | ||
| 0.247 | 0.159 | 0.351 | Antiobesity | 0.287 0.125 DBMET01888 0.287 0.125 DBMET01890 0.351 0.087 DBMET01892 0.33 0.097 DBMET01889 0.33 0.097 DBMET01891 0.233 0.174 DBMET01895 | DBMET01892 | |
| 0.183 | 0.097 | 0.19 | 5 Hydroxytryptamine 3E antagonist | 0.182 0.1 DBMET01892 0.19 0.081 DBMET01894 | DBMET01894 | |
| 0.095 | 0.008 | 0.289 | 5 Hydroxytryptamine 2C agonist | 0.066 0.017 DBMET01888 0.066 0.017 DBMET01890 0.289 0.004 DBMET01892 0.059 0.021 DBMET01893 0.063 0.019 DBMET01894 | DBMET01892 | |
| 0.139 | 0.054 | 0.164 | TRKB antagonist | 0.123 0.069 DBMET01888 0.123 0.069 DBMET01890 0.164 0.039 DBMET01892 | DBMET01892 | |
| 0.14 | 0.055 | 0.186 | TRKA antagonist | 0.128 0.061 DBMET01888 0.128 0.061 DBMET01890 0.186 0.034 DBMET01892 0.104 0.084 DBMET01894 | DBMET01892 | |
| 0.1 | 0.015 | 0.106 | Phospholipase D inhibitor | 0.097 0.016 DBMET01888 0.097 0.016 DBMET01890 0.106 0.012 DBMET01892 0.076 0.042 DBMET01895 | DBMET01892 | |
| 0.095 | 0.012 | 0.099 | Cyclin-dependent kinase 6 inhibitor | 0.093 0.013 DBMET01888 0.093 0.013 DBMET01890 0.099 0.01 DBMET01892 0.058 0.044 DBMET01894 0.06 0.042 DBMET01895 | DBMET01892 | |
| 0.175 | 0.092 | 0.333 | Amyloid beta aggregation inhibitor | 0.146 0.111 DBMET01888 0.146 0.111 DBMET01890 0.141 0.115 DBMET01892 0.14 0.116 DBMET01889 0.14 0.116 DBMET01891 0.333 0.039 DBMET01894 0.187 0.085 DBMET01895 | DBMET01894 | |
| 0.089 | 0.006 | 0.107 | Glutamate (mGluR1a) antagonist | 0.059 0.015 DBMET01892 0.107 0.005 DBMET01894 0.043 0.026 DBMET01895 | DBMET01894 | |
| 0.281 | 0.201 | 0.281 | MAP kinase 1 inhibitor | |||
| 0.089 | 0.009 | 0.155 | Poly(ADP-ribose) polymerase inhibitor | 0.046 0.028 DBMET01888 0.046 0.028 DBMET01890 0.155 0.005 DBMET01892 0.08 0.01 DBMET01893 0.052 0.021 DBMET01894 | DBMET01892 | |
| 0.104 | 0.026 | 0.172 | Alpha adrenoreceptor agonist | 0.172 0.012 DBMET01892 | DBMET01892 | |
| 0.1 | 0.023 | 0.1 | Glutamate (mGluR) agonist | 0.057 0.048 DBMET01888 0.057 0.048 DBMET01890 0.094 0.025 DBMET01892 | ||
| 0.084 | 0.007 | 0.119 | Histamine H4 receptor antagonist | 0.119 0.004 DBMET01892 0.076 0.01 DBMET01894 | DBMET01892 | |
| 0.094 | 0.018 | 0.111 | Alpha 1 adrenoreceptor agonist | 0.111 0.014 DBMET01892 | DBMET01892 | |
| 0.171 | 0.098 | 0.199 | I kappa B kinase epsilon inhibitor | 0.199 0.072 DBMET01892 0.139 0.132 DBMET01894 | DBMET01892 | |
| 0.119 | 0.046 | 0.127 | Antiadrenergic | 0.08 0.071 DBMET01888 0.08 0.071 DBMET01890 0.127 0.043 DBMET01892 0.127 0.043 DBMET01893 | DBMET01893 | |
| 0.091 | 0.018 | 0.156 | 5 Hydroxytryptamine 5A antagonist | 0.132 0.01 DBMET01892 0.156 0.007 DBMET01894 | DBMET01894 | |
| 0.102 | 0.03 | 0.102 | Phosphodiesterase XI inhibitor | 0.075 0.072 DBMET01888 0.075 0.072 DBMET01890 | ||
| 0.102 | 0.03 | 0.102 | Phosphodiesterase 11A inhibitor | 0.075 0.072 DBMET01888 0.075 0.072 DBMET01890 | ||
| 0.116 | 0.045 | 0.124 | Adrenaline antagonist | 0.077 0.071 DBMET01888 0.077 0.071 DBMET01890 0.124 0.042 DBMET01892 0.124 0.042 DBMET01893 | DBMET01893 | |
| 0.157 | 0.087 | 0.187 | Antipruritic | 0.159 0.085 DBMET01888 0.159 0.085 DBMET01890 0.187 0.058 DBMET01892 | DBMET01892 | |
| 0.098 | 0.028 | 0.098 | Dopamine agonist | 0.06 0.052 DBMET01888 0.06 0.052 DBMET01890 | ||
| 0.083 | 0.013 | 0.125 | Histamine agonist | 0.125 0.006 DBMET01892 0.079 0.014 DBMET01894 | DBMET01892 | |
| 0.104 | 0.034 | 0.132 | Alpha 1b adrenoreceptor antagonist | 0.132 0.026 DBMET01892 0.073 0.051 DBMET01893 | DBMET01892 | |
| 0.09 | 0.02 | 0.144 | 5 Hydroxytryptamine 3 agonist | 0.144 0.005 DBMET01892 | DBMET01892 | |
| 0.121 | 0.052 | 0.125 | Granulocyte macrophage colony stimulating factor antagonist | 0.125 0.049 DBMET01892 0.102 0.068 DBMET01893 | DBMET01892 | |
| 0.131 | 0.065 | 0.197 | Protein kinase (CK1) delta inhibitor | 0.197 0.03 DBMET01892 0.172 0.041 DBMET01894 | DBMET01892 | |
| 0.126 | 0.062 | 0.277 | Topoisomerase II inhibitor | 0.134 0.057 DBMET01888 0.134 0.057 DBMET01890 0.133 0.058 DBMET01892 0.277 0.021 DBMET01889 0.277 0.021 DBMET01891 0.124 0.064 DBMET01894 0.107 0.079 DBMET01895 | DBMET01891 | |
| 0.07 | 0.006 | 0.095 | Vascular adhesion protein 1 inhibitor | 0.047 0.018 DBMET01888 0.047 0.018 DBMET01890 0.095 0.004 DBMET01892 0.038 0.028 DBMET01894 | DBMET01892 | |
| 0.073 | 0.01 | 0.129 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.035 0.03 DBMET01888 0.035 0.03 DBMET01890 0.129 0.005 DBMET01892 0.072 0.01 DBMET01893 0.043 0.021 DBMET01894 | DBMET01892 | |
| 0.111 | 0.048 | 0.115 | Creatine kinase inhibitor | 0.115 0.045 DBMET01888 0.115 0.045 DBMET01890 | DBMET01890 | |
| 0.108 | 0.047 | 0.108 | mTOR complex 1 inhibitor | 0.106 0.05 DBMET01888 0.106 0.05 DBMET01890 0.099 0.064 DBMET01892 | ||
| 0.08 | 0.019 | 0.08 | Dopamine D4 agonist | |||
| 0.077 | 0.017 | 0.077 | Histamine H3 receptor antagonist | 0.042 0.032 DBMET01892 | ||
| 0.08 | 0.021 | 0.174 | 5 Hydroxytryptamine 5 antagonist | 0.128 0.01 DBMET01892 0.174 0.005 DBMET01894 0.053 0.05 DBMET01895 | DBMET01894 | |
| 0.065 | 0.007 | 0.202 | 5 Hydroxytryptamine 2B agonist | 0.037 0.033 DBMET01888 0.037 0.033 DBMET01890 0.202 0.003 DBMET01892 0.04 0.025 DBMET01893 0.054 0.011 DBMET01894 | DBMET01892 | |
| 0.122 | 0.065 | 0.122 | Acetylcholine muscarinic antagonist | 0.118 0.069 DBMET01888 0.118 0.069 DBMET01890 0.096 0.095 DBMET01892 | ||
| 0.152 | 0.098 | 0.167 | Tumour necrosis factor antagonist | 0.167 0.08 DBMET01888 0.167 0.08 DBMET01890 0.155 0.094 DBMET01892 | DBMET01890 | |
| 0.086 | 0.032 | 0.088 | Phosphodiesterase 4B inhibitor | 0.088 0.031 DBMET01888 0.088 0.031 DBMET01890 0.063 0.052 DBMET01892 | DBMET01890 | |
| 0.196 | 0.144 | 0.196 | Transcription factor STAT inhibitor | 0.191 0.151 DBMET01892 | ||
| 0.09 | 0.038 | 0.103 | Interferon agonist | 0.092 0.037 DBMET01888 0.092 0.037 DBMET01890 0.072 0.067 DBMET01892 0.103 0.026 DBMET01889 0.103 0.026 DBMET01891 0.08 0.052 DBMET01894 0.083 0.048 DBMET01895 | DBMET01891 | |
| 0.077 | 0.026 | 0.077 | Acetylcholine M5 receptor antagonist | 0.054 0.051 DBMET01888 0.054 0.051 DBMET01890 | ||
| 0.06 | 0.009 | 0.06 | Acid-sensing ion channel blocker | 0.052 0.014 DBMET01888 0.052 0.014 DBMET01890 0.058 0.01 DBMET01892 0.038 0.032 DBMET01893 0.039 0.03 DBMET01889 0.039 0.03 DBMET01891 0.039 0.03 DBMET01894 | ||
| 0.068 | 0.018 | 0.068 | Potassium channel (Inward rectifier) blocker | 0.054 0.029 DBMET01888 0.054 0.029 DBMET01890 0.059 0.024 DBMET01892 | ||
| 0.1 | 0.051 | 0.136 | Protein kinase C zeta inhibitor | 0.105 0.045 DBMET01888 0.105 0.045 DBMET01890 0.136 0.024 DBMET01892 0.126 0.029 DBMET01894 | DBMET01892 | |
| 0.107 | 0.06 | 0.201 | MAP kinase kinase kinase inhibitor | 0.102 0.064 DBMET01892 0.201 0.018 DBMET01894 0.156 0.032 DBMET01895 | DBMET01894 | |
| 0.075 | 0.031 | 0.075 | Cannabinoid CB1 receptor agonist | |||
| 0.077 | 0.034 | 0.097 | Protein kinase C beta inhibitor | 0.083 0.026 DBMET01888 0.083 0.026 DBMET01890 0.097 0.015 DBMET01892 0.07 0.048 DBMET01894 | DBMET01892 | |
| 0.048 | 0.006 | 0.054 | DNA topoisomerase IV inhibitor | 0.037 0.011 DBMET01888 0.037 0.011 DBMET01890 0.054 0.005 DBMET01892 0.033 0.014 DBMET01893 0.033 0.014 DBMET01889 0.033 0.014 DBMET01891 | DBMET01892 | |
| 0.052 | 0.01 | 0.052 | Potassium channel small-conductance Ca-activated activator | 0.048 0.012 DBMET01892 | ||
| 0.09 | 0.048 | 0.112 | AXL receptor tyrosine kinase inhibitor | 0.112 0.031 DBMET01888 0.112 0.031 DBMET01890 0.097 0.042 DBMET01892 | DBMET01890 | |
| 0.186 | 0.145 | 0.371 | DNA synthesis inhibitor | 0.253 0.064 DBMET01888 0.253 0.064 DBMET01890 0.198 0.127 DBMET01892 0.371 0.026 DBMET01889 0.371 0.026 DBMET01891 0.192 0.136 DBMET01895 | DBMET01891 | |
| 0.08 | 0.041 | 0.08 | Phosphodiesterase VI inhibitor | 0.069 0.064 DBMET01888 0.069 0.064 DBMET01890 | ||
| 0.092 | 0.054 | 0.105 | Histamine N-methyltransferase inhibitor | 0.079 0.068 DBMET01892 0.105 0.041 DBMET01894 | DBMET01894 | |
| 0.052 | 0.015 | 0.096 | Alpha 1d adrenoreceptor agonist | 0.096 0.004 DBMET01892 0.082 0.005 DBMET01894 0.038 0.028 DBMET01895 | DBMET01892 | |
| 0.071 | 0.033 | 0.082 | Interferon inducer | 0.073 0.031 DBMET01888 0.073 0.031 DBMET01890 0.059 0.056 DBMET01892 0.082 0.022 DBMET01889 0.082 0.022 DBMET01891 0.064 0.045 DBMET01894 0.065 0.044 DBMET01895 | DBMET01891 | |
| 0.095 | 0.059 | 0.104 | Alpha 2d adrenoreceptor antagonist | 0.104 0.042 DBMET01892 | DBMET01892 | |
| 0.071 | 0.035 | 0.071 | DNA gyrase inhibitor | 0.056 0.055 DBMET01888 0.056 0.055 DBMET01890 0.059 0.05 DBMET01892 0.067 0.039 DBMET01889 0.067 0.039 DBMET01891 | ||
| 0.085 | 0.051 | 0.099 | Neuropeptide Y antagonist | 0.099 0.041 DBMET01894 | DBMET01894 | |
| 0.077 | 0.043 | 0.077 | Potassium channel (Tandem pore domain) blocker | 0.072 0.058 DBMET01892 | ||
| 0.06 | 0.026 | 0.094 | Transforming growth factor beta 1 antagonist | 0.094 0.011 DBMET01892 0.056 0.029 DBMET01894 | DBMET01892 | |
| 0.068 | 0.036 | 0.082 | Alpha 1d adrenoreceptor antagonist | 0.082 0.029 DBMET01892 | DBMET01892 | |
| 0.141 | 0.109 | 0.203 | TRKC antagonist | 0.133 0.118 DBMET01888 0.133 0.118 DBMET01890 0.203 0.066 DBMET01892 0.164 0.09 DBMET01894 | DBMET01892 | |
| 0.09 | 0.058 | 0.09 | Phosphodiesterase I inhibitor | |||
| 0.066 | 0.034 | 0.066 | Corticotropin releasing factor 2 receptor antagonist | 0.065 0.035 DBMET01892 0.066 0.035 DBMET01894 | ||
| 0.041 | 0.009 | 0.048 | CDK4/cyclin D3 inhibitor | 0.048 0.007 DBMET01892 0.032 0.016 DBMET01894 | DBMET01892 | |
| 0.08 | 0.048 | 0.141 | MAP kinase 11 inhibitor | 0.141 0.019 DBMET01892 0.134 0.021 DBMET01894 0.069 0.056 DBMET01895 | DBMET01892 | |
| 0.059 | 0.029 | 0.059 | Autotaxin inhibitor | 0.058 0.03 DBMET01888 0.058 0.03 DBMET01890 | ||
| 0.041 | 0.011 | 0.073 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.073 0.006 DBMET01892 | DBMET01892 | |
| 0.053 | 0.025 | 0.053 | Dopamine D2 agonist | |||
| 0.052 | 0.024 | 0.056 | Cytokine production stimulant | 0.056 0.018 DBMET01889 0.056 0.018 DBMET01891 0.051 0.027 DBMET01894 | DBMET01891 | |
| 0.05 | 0.022 | 0.05 | Phosphodiesterase 6C inhibitor | |||
| 0.108 | 0.081 | 0.108 | Calcium channel N-type blocker | |||
| 0.044 | 0.018 | 0.044 | DNA gyrase subunit B inhibitor | |||
| 0.181 | 0.157 | 0.221 | Neuropeptide Y2 antagonist | 0.221 0.088 DBMET01894 | DBMET01894 | |
| 0.089 | 0.064 | 0.157 | Protein kinase C delta inhibitor | 0.086 0.067 DBMET01888 0.086 0.067 DBMET01890 0.157 0.019 DBMET01892 0.101 0.052 DBMET01893 0.144 0.024 DBMET01894 | DBMET01892 | |
| 0.082 | 0.058 | 0.166 | MAP-kinase-activated kinase inhibitor | 0.166 0.01 DBMET01892 0.131 0.021 DBMET01894 0.074 0.071 DBMET01895 | DBMET01892 | |
| 0.103 | 0.08 | 0.103 | Acetylcholine release stimulant | 0.102 0.083 DBMET01892 | ||
| 0.082 | 0.059 | 0.112 | Phosphodiesterase IV inhibitor | 0.11 0.038 DBMET01888 0.11 0.038 DBMET01890 0.078 0.064 DBMET01892 0.112 0.037 DBMET01893 | DBMET01893 | |
| 0.07 | 0.048 | 0.093 | Transforming growth factor antagonist | 0.093 0.025 DBMET01892 0.065 0.056 DBMET01894 | DBMET01892 | |
| 0.045 | 0.023 | 0.045 | Dopamine D3 agonist | |||
| 0.047 | 0.026 | 0.065 | Dipeptidyl peptidase IV inhibitor | 0.065 0.011 DBMET01892 0.049 0.021 DBMET01894 | DBMET01892 | |
| 0.06 | 0.039 | 0.126 | Glutamate (mGluR1) antagonist | 0.075 0.027 DBMET01892 0.126 0.01 DBMET01894 0.079 0.024 DBMET01895 | DBMET01894 | |
| 0.103 | 0.083 | 0.107 | Interleukin 2 antagonist | 0.107 0.072 DBMET01892 0.101 0.089 DBMET01894 | DBMET01892 | |
| 0.054 | 0.035 | 0.076 | Dipeptidyl peptidase inhibitor | 0.076 0.015 DBMET01892 0.059 0.026 DBMET01894 | DBMET01892 | |
| 0.072 | 0.054 | 0.154 | MAP-kinase-activated kinase 2 inhibitor | 0.154 0.01 DBMET01892 0.124 0.019 DBMET01894 0.068 0.061 DBMET01895 | DBMET01892 | |
| 0.066 | 0.049 | 0.121 | Protein kinase C alpha inhibitor | 0.061 0.059 DBMET01888 0.061 0.059 DBMET01890 0.121 0.015 DBMET01892 0.099 0.023 DBMET01894 | DBMET01892 | |
| 0.033 | 0.017 | 0.033 | Complement C5a chemotactic receptor antagonist | 0.031 0.018 DBMET01892 | ||
| 0.122 | 0.106 | 0.122 | Death-associated protein kinase 1 inhibitor | |||
| 0.032 | 0.016 | 0.032 | Potassium channel (Inward rectifier) 1 blocker | 0.03 0.021 DBMET01888 0.03 0.021 DBMET01890 0.028 0.027 DBMET01892 | ||
| 0.043 | 0.028 | 0.058 | Smo receptor antagonist | 0.058 0.02 DBMET01892 | DBMET01892 | |
| 0.041 | 0.026 | 0.042 | Cyclin D3 inhibitor | 0.042 0.025 DBMET01892 | DBMET01892 | |
| 0.079 | 0.064 | 0.088 | Caspase 7 inhibitor | 0.088 0.046 DBMET01892 | DBMET01892 | |
| 0.033 | 0.018 | 0.04 | LIM domain kinase 2 inhibitor | 0.04 0.009 DBMET01892 | DBMET01892 | |
| 0.125 | 0.11 | 0.259 | Cyclin-dependent kinase 8 inhibitor | 0.134 0.097 DBMET01888 0.134 0.097 DBMET01890 0.18 0.052 DBMET01892 0.259 0.014 DBMET01894 0.129 0.104 DBMET01895 | DBMET01894 | |
| 0.081 | 0.067 | 0.081 | mTOR complex 2 inhibitor | |||
| 0.043 | 0.03 | 0.043 | Nerve growth factor antagonist | |||
| 0.151 | 0.138 | 0.179 | Histone acetyltransferase inhibitor | 0.179 0.1 DBMET01892 | DBMET01892 | |
| 0.05 | 0.038 | 0.05 | mTOR inhibitor | 0.046 0.044 DBMET01892 | ||
| 0.096 | 0.085 | 0.112 | DOPA decarboxylase inhibitor | 0.112 0.055 DBMET01895 | DBMET01895 | |
| 0.146 | 0.137 | 0.194 | Focal adhesion kinase 2 inhibitor | 0.194 0.074 DBMET01892 | DBMET01892 | |
| 0.048 | 0.039 | 0.048 | Neuropeptide Y5 antagonist | |||
| 0.085 | 0.078 | 0.087 | Phosphodiesterase 7B inhibitor | 0.087 0.075 DBMET01892 | DBMET01892 | |
| 0.084 | 0.077 | 0.095 | Glutamate release inhibitor | 0.088 0.067 DBMET01889 0.088 0.067 DBMET01891 0.095 0.051 DBMET01894 0.092 0.057 DBMET01895 | DBMET01894 | |
| 0.09 | 0.083 | 0.239 | Ferrochelatase inhibitor | 0.126 0.05 DBMET01894 0.239 0.015 DBMET01895 | DBMET01895 | |
| 0.056 | 0.05 | 0.097 | 5 Hydroxytryptamine uptake inhibitor | 0.097 0.027 DBMET01892 | DBMET01892 | |
| 0.074 | 0.068 | 0.111 | ALK inhibitor | 0.111 0.035 DBMET01892 | DBMET01892 | |
| 0.049 | 0.044 | 0.052 | 5 Hydroxytryptamine 1B agonist | 0.052 0.038 DBMET01892 | DBMET01892 | |
| 0.057 | 0.052 | 0.07 | 5 Hydroxytryptamine 1D antagonist | 0.07 0.038 DBMET01892 | DBMET01892 | |
| 0.054 | 0.051 | 0.128 | Alpha 2 adrenoreceptor agonist | 0.128 0.009 DBMET01892 | DBMET01892 | |
| 0.056 | 0.052 | 0.056 | Cannabinoid receptor agonist | |||
| 0.059 | 0.056 | 0.064 | Prolactin release inhibitor | 0.06 0.052 DBMET01892 0.064 0.039 DBMET01894 0.061 0.047 DBMET01895 | DBMET01894 | |
| 0.017 | 0.015 | 0.042 | Histamine H4 receptor agonist | 0.042 0.005 DBMET01892 0.017 0.014 DBMET01894 | DBMET01892 | |
| 0.154 | 0.153 | 0.454 | Tumour necrosis factor alpha release inhibitor | 0.257 0.072 DBMET01888 0.257 0.072 DBMET01890 0.165 0.139 DBMET01892 0.454 0.019 DBMET01893 0.434 0.021 DBMET01889 0.434 0.021 DBMET01891 | DBMET01893 | |
| 0.028 | 0.026 | 0.028 | Phosphodiesterase 6B inhibitor | |||
| 0.075 | 0.074 | 0.079 | Insulin growth factor antagonist | 0.079 0.068 DBMET01892 | DBMET01892 | |
| 0.099 | 0.098 | 0.107 | RET inhibitor | 0.107 0.089 DBMET01892 | DBMET01892 | |
| 0.168 | 0.168 | 0.246 | 5 Hydroxytryptamine 1E antagonist | 0.225 0.102 DBMET01892 0.246 0.079 DBMET01894 | DBMET01894 | |
| 0.088 | 0.088 | 0.14 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.14 0.057 DBMET01892 0.095 0.083 DBMET01894 | DBMET01892 | |
| 0.063 | 0.064 | 0.08 | Vanilloid antagonist | 0.08 0.047 DBMET01888 0.08 0.047 DBMET01890 0.077 0.049 DBMET01892 | DBMET01890 | |
| 0.057 | 0.058 | 0.08 | Vanilloid 1 antagonist | 0.08 0.037 DBMET01888 0.08 0.037 DBMET01890 | DBMET01890 | |
| 0.072 | 0.073 | 0.075 | Insulin like growth factor 1 antagonist | 0.075 0.068 DBMET01892 | DBMET01892 | |
| 0.039 | 0.041 | 0.049 | Potassium channel small-conductance Ca-activated blocker | 0.046 0.029 DBMET01892 0.049 0.026 DBMET01894 | DBMET01894 | |
| 0.054 | 0.056 | 0.062 | Potassium channel (Ca-activated) blocker | 0.062 0.039 DBMET01894 | DBMET01894 | |
| 0.061 | 0.064 | 0.188 | MAP kinase 14 inhibitor | 0.092 0.04 DBMET01892 0.188 0.013 DBMET01894 0.103 0.034 DBMET01895 | DBMET01894 | |
| 0.053 | 0.057 | 0.059 | Ca(v)3.2 blocker | 0.059 0.039 DBMET01892 | DBMET01892 | |
| 0.065 | 0.069 | 0.081 | Glutamate (mGluR) antagonist | 0.075 0.054 DBMET01892 0.081 0.048 DBMET01894 | DBMET01894 | |
| 0.047 | 0.052 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.045 DBMET01892 | DBMET01892 | |
| 0.121 | 0.127 | 0.138 | Pregnane X receptor agonist | 0.138 0.077 DBMET01888 0.138 0.077 DBMET01890 0.126 0.111 DBMET01892 | DBMET01890 | |
| 0.052 | 0.058 | 0.076 | Heat shock protein 90 beta antagonist | 0.076 0.024 DBMET01888 0.076 0.024 DBMET01890 | DBMET01890 | |
| 0.048 | 0.057 | 0.234 | Protein kinase C iota inhibitor | 0.097 0.019 DBMET01892 0.234 0.004 DBMET01894 0.078 0.027 DBMET01895 | DBMET01894 | |
| 0.08 | 0.089 | 0.093 | Potassium channel (Voltage-sensitive) activator | 0.093 0.063 DBMET01892 | DBMET01892 | |
| 0.102 | 0.112 | 0.133 | Growth factor antagonist | 0.133 0.081 DBMET01893 | DBMET01893 | |
| 0.024 | 0.035 | 0.029 | 5 Hydroxytryptamine 6 agonist | 0.029 0.02 DBMET01892 | DBMET01892 | |
| 0.052 | 0.064 | 0.085 | Toll-Like receptor 7 antagonist | 0.085 0.033 DBMET01892 | DBMET01892 | |
| 0.023 | 0.035 | 0.039 | Purinergic P2Y14 antagonist | 0.039 0.012 DBMET01892 0.027 0.025 DBMET01894 0.028 0.024 DBMET01895 | DBMET01892 | |
| 0.098 | 0.11 | 0.19 | Protein kinase (CK1) inhibitor | 0.183 0.047 DBMET01892 0.19 0.044 DBMET01894 | DBMET01894 | |
| 0.041 | 0.053 | 0.06 | Diacylglycerol O-acyltransferase inhibitor | 0.054 0.031 DBMET01892 0.06 0.026 DBMET01895 | DBMET01895 | |
| 0.032 | 0.046 | 0.046 | Glucose-6-phosphate dehydrogenase inhibitor | 0.046 0.015 DBMET01888 0.046 0.015 DBMET01890 | DBMET01890 | |
| 0.043 | 0.058 | 0.049 | Antiviral (Hepatitis D) | 0.049 0.038 DBMET01892 | DBMET01892 | |
| 0.014 | 0.03 | 0.041 | Imidazoline I1 receptor antagonist | 0.041 0.005 DBMET01892 0.019 0.017 DBMET01894 | DBMET01892 | |
| 0.043 | 0.059 | 0.052 | Dopamine uptake inhibitor | 0.052 0.047 DBMET01892 | DBMET01892 | |
| 0.045 | 0.061 | 0.107 | CXC chemokine 4 receptor antagonist | 0.107 0.023 DBMET01892 0.09 0.027 DBMET01894 | DBMET01892 | |
| 0.069 | 0.086 | 0.089 | Acetylcholine agonist | 0.089 0.056 DBMET01892 | DBMET01892 | |
| 0.027 | 0.046 | 0.037 | Transforming growth factor beta 2 antagonist | 0.037 0.016 DBMET01892 | DBMET01892 | |
| 0.069 | 0.089 | 0.111 | MAP kinase kinase 7 inhibitor | 0.084 0.037 DBMET01888 0.084 0.037 DBMET01890 0.1 0.013 DBMET01892 0.111 0.006 DBMET01894 0.08 0.047 DBMET01895 | DBMET01894 | |
| 0.033 | 0.053 | 0.046 | Stearoyl-CoA desaturase inhibitor | 0.046 0.028 DBMET01892 | DBMET01892 | |
| 0.031 | 0.052 | 0.055 | Protein kinase (CK1) epsilon inhibitor | 0.055 0.01 DBMET01892 | DBMET01892 | |
| 0.056 | 0.078 | 0.101 | Rho-associated kinase I inhibitor | 0.074 0.053 DBMET01892 0.101 0.031 DBMET01894 | DBMET01894 | |
| 0.053 | 0.078 | 0.076 | Phosphodiesterase 4D inhibitor | 0.076 0.05 DBMET01888 0.076 0.05 DBMET01890 | DBMET01890 | |
| 0.072 | 0.1 | 0.08 | Bromodomain-containing protein 2 inhibitor | 0.08 0.078 DBMET01892 | DBMET01892 | |
| 0.015 | 0.043 | 0.025 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.025 0.024 DBMET01892 | DBMET01892 | |
| 0.026 | 0.054 | 0.036 | Glutamate (mGluR group II) antagonist | 0.036 0.029 DBMET01892 | DBMET01892 | |
| 0.009 | 0.039 | 0.023 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.023 0.012 DBMET01888 0.023 0.012 DBMET01890 | DBMET01890 | |
| 0.078 | 0.108 | 0.106 | Estrogen receptor beta antagonist | 0.106 0.054 DBMET01888 0.106 0.054 DBMET01890 | DBMET01890 | |
| 0.074 | 0.104 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.115 0.036 DBMET01888 0.115 0.036 DBMET01890 | DBMET01890 | |
| 0.108 | 0.138 | 0.14 | Aurora-C kinase inhibitor | 0.129 0.085 DBMET01892 0.14 0.065 DBMET01894 | DBMET01894 | |
| 0.048 | 0.08 | 0.138 | I kappa B kinase 2 inhibitor | 0.097 0.014 DBMET01892 0.138 0.006 DBMET01894 | DBMET01894 | |
| 0.106 | 0.138 | 0.237 | Insulin secretagoues | 0.137 0.089 DBMET01888 0.137 0.089 DBMET01890 0.233 0.023 DBMET01889 0.233 0.023 DBMET01891 0.237 0.022 DBMET01895 | DBMET01895 | |
| 0.07 | 0.102 | 0.147 | Pim-3 kinase inhibitor | 0.134 0.024 DBMET01892 0.147 0.019 DBMET01894 | DBMET01894 | |
| 0.093 | 0.126 | 0.129 | NADPH oxidase inhibitor | 0.129 0.072 DBMET01892 | DBMET01892 | |
| 0.044 | 0.078 | 0.073 | Cyclin-dependent kinase 4 inhibitor | 0.073 0.039 DBMET01892 | DBMET01892 | |
| 0.09 | 0.124 | 0.119 | Estrogen antagonist | 0.119 0.057 DBMET01888 0.119 0.057 DBMET01890 | DBMET01890 | |
| 0.04 | 0.075 | 0.063 | Protein kinase C theta inhibitor | 0.063 0.032 DBMET01892 | DBMET01892 | |
| 0.015 | 0.05 | 0.041 | 5 Hydroxytryptamine 1F agonist | 0.041 0.007 DBMET01894 0.028 0.015 DBMET01895 | DBMET01894 | |
| 0.139 | 0.176 | 0.286 | Spasmolytic | 0.17 0.145 DBMET01888 0.17 0.145 DBMET01890 0.286 0.076 DBMET01889 0.286 0.076 DBMET01891 | DBMET01891 | |
| 0.086 | 0.123 | 0.171 | Photosensitizer | 0.103 0.083 DBMET01892 0.102 0.084 DBMET01889 0.102 0.084 DBMET01891 0.143 0.035 DBMET01894 0.171 0.021 DBMET01895 | DBMET01895 | |
| 0.019 | 0.057 | 0.026 | Myristoyl transferase inhibitor | 0.026 0.02 DBMET01892 | DBMET01892 | |
| 0.04 | 0.077 | 0.06 | Alpha 1b adrenoreceptor agonist | 0.06 0.019 DBMET01892 | DBMET01892 | |
| 0.035 | 0.073 | 0.068 | Toll-Like receptor 8 antagonist | 0.068 0.025 DBMET01892 | DBMET01892 | |
| 0.061 | 0.1 | 0.075 | Estrogen receptor alpha antagonist | 0.075 0.056 DBMET01888 0.075 0.056 DBMET01890 | DBMET01890 | |
| 0.026 | 0.067 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.025 DBMET01895 | DBMET01895 | |
| 0.053 | 0.094 | 0.086 | Nicotinic alpha4beta2 receptor antagonist | 0.086 0.044 DBMET01892 | DBMET01892 | |
| 0.041 | 0.084 | 0.074 | Adrenaline uptake inhibitor | 0.074 0.031 DBMET01892 | DBMET01892 | |
| 0.02 | 0.064 | 0.11 | Kinesin antagonist | 0.11 0.007 DBMET01894 | DBMET01894 | |
| 0.02 | 0.064 | 0.11 | Kinesin-like protein 1 inhibitor | 0.11 0.007 DBMET01894 | DBMET01894 | |
| 0.031 | 0.076 | 0.043 | Histamine H1 receptor agonist | 0.043 0.031 DBMET01892 0.042 0.036 DBMET01894 | DBMET01892 | |
| 0.045 | 0.091 | 0.075 | CDK1/cyclin B1 inhibitor | 0.064 0.055 DBMET01892 0.075 0.043 DBMET01894 | DBMET01894 | |
| 0.023 | 0.071 | 0.036 | ATR kinase inhibitor | 0.036 0.017 DBMET01892 | DBMET01892 | |
| 0.038 | 0.087 | 0.069 | Cyclin A2 inhibitor | 0.069 0.04 DBMET01892 0.067 0.041 DBMET01894 | DBMET01892 | |
| 0.019 | 0.069 | 0.03 | MAP3K8 inhibitor | 0.03 0.018 DBMET01894 0.027 0.025 DBMET01895 | DBMET01894 | |
| 0.181 | 0.233 | 0.311 | 15-Lipoxygenase inhibitor | 0.253 0.162 DBMET01894 0.311 0.125 DBMET01895 | DBMET01895 | |
| 0.032 | 0.085 | 0.05 | GABA A receptor antagonist | 0.05 0.04 DBMET01892 | DBMET01892 | |
| 0.163 | 0.217 | 0.211 | Tyrosine 3 hydroxylase inhibitor | 0.195 0.145 DBMET01892 0.211 0.117 DBMET01895 | DBMET01895 | |
| 0.117 | 0.174 | 0.195 | Lipocortins synthesis antagonist | 0.181 0.07 DBMET01888 0.181 0.07 DBMET01890 0.142 0.117 DBMET01889 0.142 0.117 DBMET01891 0.195 0.06 DBMET01895 | DBMET01895 | |
| 0.081 | 0.139 | 0.147 | Vascular endothelial growth factor 3 antagonist | 0.123 0.092 DBMET01892 0.147 0.069 DBMET01894 | DBMET01894 | |
| 0.169 | 0.227 | 0.222 | 5 Hydroxytryptamine uptake stimulant | 0.222 0.114 DBMET01892 0.215 0.125 DBMET01894 0.211 0.132 DBMET01895 | DBMET01892 | |
| 0.031 | 0.09 | 0.053 | GABA receptor antagonist | 0.053 0.039 DBMET01892 | DBMET01892 | |
| 0.099 | 0.158 | 0.205 | Hexokinase inhibitor | 0.121 0.117 DBMET01888 0.121 0.117 DBMET01890 0.205 0.032 DBMET01889 0.205 0.032 DBMET01891 | DBMET01891 | |
| 0.102 | 0.161 | 0.214 | Polo-like kinase-3 inhibitor | 0.214 0.038 DBMET01893 0.128 0.113 DBMET01894 0.126 0.115 DBMET01895 | DBMET01893 | |
| 0.152 | 0.217 | 0.233 | Hypoxia-inducible factor 1 alpha inhibitor | 0.205 0.146 DBMET01888 0.205 0.146 DBMET01890 0.233 0.116 DBMET01892 0.224 0.125 DBMET01889 0.224 0.125 DBMET01891 0.18 0.179 DBMET01895 | DBMET01892 | |
| 0.102 | 0.168 | 0.274 | LIM domain kinase 1 inhibitor | 0.177 0.076 DBMET01892 0.274 0.028 DBMET01894 | DBMET01894 | |
| 0.011 | 0.076 | 0.021 | Alpha 1a adrenoreceptor agonist | 0.021 0.017 DBMET01892 | DBMET01892 | |
| 0.032 | 0.098 | 0.09 | Protein kinase C eta inhibitor | 0.09 0.02 DBMET01894 | DBMET01894 | |
| 0.032 | 0.098 | 0.063 | Cyclin A inhibitor | 0.06 0.044 DBMET01892 0.063 0.042 DBMET01894 | DBMET01894 | |
| 0.031 | 0.097 | 0.126 | p38 MAP kinase inhibitor | 0.06 0.052 DBMET01892 0.126 0.024 DBMET01894 | DBMET01894 | |
| 0.053 | 0.12 | 0.108 | Cyclin-dependent kinase 1 inhibitor | 0.108 0.061 DBMET01894 | DBMET01894 | |
| 0.053 | 0.12 | 0.178 | I kappa B kinase inhibitor | 0.119 0.027 DBMET01892 0.178 0.01 DBMET01894 | DBMET01894 | |
| 0.031 | 0.101 | 0.103 | Pim-2 kinase inhibitor | 0.066 0.026 DBMET01892 0.103 0.014 DBMET01894 | DBMET01894 | |
| 0.023 | 0.093 | 0.061 | Geranyltranstransferase inhibitor | 0.045 0.029 DBMET01894 0.061 0.013 DBMET01895 | DBMET01895 | |
| 0.036 | 0.107 | 0.075 | Sphingosine 1-phosphate receptor 4 agonist | 0.075 0.041 DBMET01895 | DBMET01895 | |
| 0.072 | 0.143 | 0.13 | Glutamate receptor antagonist | 0.099 0.098 DBMET01892 0.123 0.071 DBMET01894 0.13 0.065 DBMET01895 | DBMET01895 | |
| 0.02 | 0.094 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DBMET01888 0.034 0.027 DBMET01890 | DBMET01890 | |
| 0.03 | 0.105 | 0.059 | Alpha 1L adrenoreceptor agonist | 0.059 0.009 DBMET01892 | DBMET01892 | |
| 0.11 | 0.185 | 0.38 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.38 0.021 DBMET01894 | DBMET01894 | |
| 0.113 | 0.19 | 0.392 | Death-associated protein kinase 3 inhibitor | 0.392 0.018 DBMET01894 0.148 0.125 DBMET01895 | DBMET01894 | |
| 0.047 | 0.124 | 0.09 | Acetylcholine nicotinic agonist | 0.09 0.045 DBMET01892 | DBMET01892 | |
| 0.013 | 0.092 | 0.027 | Calcium-sensing receptor agonist | 0.027 0.017 DBMET01894 0.024 0.023 DBMET01895 | DBMET01894 | |
| 0.005 | 0.085 | 0.046 | Prostaglandin D2 antagonist | 0.046 0.007 DBMET01895 | DBMET01895 | |
| 0.061 | 0.143 | 0.096 | Aurora-B kinase inhibitor | 0.096 0.087 DBMET01892 0.096 0.087 DBMET01894 | DBMET01894 | |
| 0.151 | 0.234 | 0.19 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.19 0.169 DBMET01888 0.19 0.169 DBMET01890 0.188 0.172 DBMET01894 | DBMET01890 | |
| 0.016 | 0.1 | 0.037 | HMG CoA reductase inhibitor | 0.037 0.019 DBMET01888 0.037 0.019 DBMET01890 | DBMET01890 | |
| 0.081 | 0.165 | 0.155 | Histone deacetylase SIRT1 inhibitor | 0.108 0.107 DBMET01892 0.155 0.058 DBMET01894 | DBMET01894 | |
| 0.03 | 0.114 | 0.059 | Acetylcholine M5 receptor agonist | 0.059 0.056 DBMET01892 | DBMET01892 | |
| 0.006 | 0.094 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET01892 | DBMET01892 | |
| 0.035 | 0.124 | 0.055 | Sphingosine 1-phosphate receptor 5 agonist | 0.055 0.035 DBMET01895 | DBMET01895 | |
| 0.025 | 0.114 | 0.063 | NMDA 2C receptor antagonist | 0.063 0.041 DBMET01892 | DBMET01892 | |
| 0.028 | 0.117 | 0.041 | Glutamate (mGluR group III) antagonist | 0.041 0.037 DBMET01895 | DBMET01895 | |
| 0.024 | 0.114 | 0.041 | Phenylethanolamine N methyltransferase inhibitor | 0.041 0.027 DBMET01892 | DBMET01892 | |
| 0.005 | 0.097 | 0.055 | Cyclin T1 inhibitor | 0.055 0.002 DBMET01894 0.031 0.005 DBMET01895 | DBMET01894 | |
| 0.054 | 0.149 | 0.104 | Ephrin antagonist | 0.104 0.06 DBMET01893 | DBMET01893 | |
| 0.009 | 0.105 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.014 DBMET01892 | DBMET01892 | |
| 0.11 | 0.206 | 0.19 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.19 0.084 DBMET01894 | DBMET01894 | |
| 0.061 | 0.159 | 0.117 | Cholesterol synthesis inhibitor | 0.117 0.068 DBMET01888 0.117 0.068 DBMET01890 | DBMET01890 | |
| 0.024 | 0.123 | 0.044 | Adenylate cyclase 1 inhibitor | 0.044 0.036 DBMET01894 | DBMET01894 | |
| 0.058 | 0.159 | 0.123 | Protein-tyrosine kinase Lyn inhibitor | 0.123 0.082 DBMET01894 | DBMET01894 | |
| 0.035 | 0.136 | 0.066 | Cyclin B3 inhibitor | 0.066 0.049 DBMET01892 | DBMET01892 | |
| 0.12 | 0.221 | 0.259 | Cardiotonic | 0.203 0.116 DBMET01888 0.203 0.116 DBMET01890 0.259 0.077 DBMET01893 | DBMET01893 | |
| 0.057 | 0.158 | 0.185 | Cyclin-dependent kinase 9 inhibitor | 0.088 0.079 DBMET01892 0.185 0.026 DBMET01894 | DBMET01894 | |
| 0.063 | 0.165 | 0.115 | Protein kinase C gamma inhibitor | 0.099 0.079 DBMET01892 0.115 0.057 DBMET01894 | DBMET01894 | |
| 0.051 | 0.155 | 0.105 | Histamine H2 receptor antagonist | 0.105 0.03 DBMET01894 | DBMET01894 | |
| 0.078 | 0.182 | 0.225 | Protein kinase (CK1) gamma 1 inhibitor | 0.225 0.034 DBMET01894 | DBMET01894 | |
| 0.114 | 0.219 | 0.195 | Death-associated protein kinase 2 inhibitor | 0.195 0.038 DBMET01894 | DBMET01894 | |
| 0.035 | 0.141 | 0.074 | CXC chemokine receptor antagonist | 0.063 0.061 DBMET01892 0.074 0.044 DBMET01894 | DBMET01894 | |
| 0.029 | 0.136 | 0.091 | CDC7 inhibitor | 0.062 0.054 DBMET01892 0.091 0.028 DBMET01894 | DBMET01894 | |
| 0.006 | 0.114 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 DBMET01892 | DBMET01892 | |
| 0.059 | 0.169 | 0.133 | Cyclin-dependent kinase inhibitor | 0.099 0.091 DBMET01892 0.133 0.065 DBMET01894 | DBMET01894 | |
| 0.041 | 0.151 | 0.07 | Secretase beta inhibitor | 0.07 0.049 DBMET01894 | DBMET01894 | |
| 0.068 | 0.178 | 0.111 | Sodium channel (voltage-gated) blocker | 0.111 0.096 DBMET01892 | DBMET01892 | |
| 0.012 | 0.124 | 0.047 | TRPM8 blocker | 0.047 0.018 DBMET01894 | DBMET01894 | |
| 0.056 | 0.171 | 0.173 | Glycogen synthase kinase-3 alpha inhibitor | 0.173 0.051 DBMET01894 | DBMET01894 | |
| 0.07 | 0.19 | 0.402 | Protein kinase C nu inhibitor | 0.11 0.105 DBMET01892 0.402 0.01 DBMET01894 0.122 0.091 DBMET01895 | DBMET01894 | |
| 0.03 | 0.15 | 0.061 | Syk tyrosine kinase inhibitor | 0.061 0.059 DBMET01894 | DBMET01894 | |
| 0.152 | 0.273 | 0.399 | Toll-Like receptor 7 agonist | 0.247 0.15 DBMET01888 0.247 0.15 DBMET01890 0.216 0.182 DBMET01889 0.216 0.182 DBMET01891 0.399 0.061 DBMET01895 | DBMET01895 | |
| 0.04 | 0.162 | 0.064 | HIV-1 integrase inhibitor | 0.064 0.059 DBMET01895 | DBMET01895 | |
| 0.057 | 0.179 | 0.103 | Interleukin 1 beta converting enzyme inhibitor | 0.103 0.054 DBMET01895 | DBMET01895 | |
| 0.039 | 0.163 | 0.085 | Protein kinase B gamma inhibitor | 0.085 0.042 DBMET01894 | DBMET01894 | |
| 0.025 | 0.149 | 0.053 | Purinergic P2X4 antagonist | 0.053 0.021 DBMET01892 | DBMET01892 | |
| 0.136 | 0.26 | 0.368 | Angiogenesis inhibitor | 0.368 0.064 DBMET01893 0.213 0.155 DBMET01889 0.213 0.155 DBMET01891 | DBMET01893 | |
| 0.026 | 0.153 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.049 0.032 DBMET01894 | DBMET01894 | |
| 0.041 | 0.167 | 0.085 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.085 0.029 DBMET01894 | DBMET01894 | |
| 0.007 | 0.134 | 0.053 | Endothelial nitric-oxide synthase inhibitor | 0.053 0.009 DBMET01894 | DBMET01894 | |
| 0.043 | 0.172 | 0.116 | Check point kinase 2 inhibitor | 0.116 0.052 DBMET01892 0.088 0.076 DBMET01894 | DBMET01892 | |
| 0.046 | 0.176 | 0.127 | Glycogen synthase kinase-3 beta inhibitor | 0.127 0.057 DBMET01894 | DBMET01894 | |
| 0.031 | 0.161 | 0.069 | Rho-associated kinase inhibitor | 0.069 0.056 DBMET01894 | DBMET01894 | |
| 0.021 | 0.152 | 0.086 | Protein kinase C epsilon inhibitor | 0.086 0.017 DBMET01894 | DBMET01894 | |
| 0.083 | 0.216 | 0.167 | Anesthetic general | 0.167 0.097 DBMET01888 0.167 0.097 DBMET01890 0.155 0.108 DBMET01889 0.155 0.108 DBMET01891 | DBMET01890 | |
| 0.148 | 0.281 | 0.409 | Toll-Like receptor agonist | 0.241 0.156 DBMET01888 0.241 0.156 DBMET01890 0.227 0.171 DBMET01889 0.227 0.171 DBMET01891 0.213 0.186 DBMET01894 0.409 0.057 DBMET01895 | DBMET01895 | |
| 0.017 | 0.152 | 0.048 | Histamine H2 receptor agonist | 0.048 0.024 DBMET01894 | DBMET01894 | |
| 0.101 | 0.239 | 0.252 | ATPase inhibitor | 0.149 0.103 DBMET01888 0.149 0.103 DBMET01890 0.252 0.013 DBMET01889 0.252 0.013 DBMET01891 | DBMET01891 | |
| 0.046 | 0.186 | 0.133 | Glycogen synthase kinase-3 inhibitor | 0.133 0.053 DBMET01894 | DBMET01894 | |
| 0.083 | 0.223 | 0.148 | Neuropeptide Y1 antagonist | 0.148 0.069 DBMET01894 | DBMET01894 | |
| 0.061 | 0.208 | 0.284 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.284 0.022 DBMET01894 | DBMET01894 | |
| 0.091 | 0.242 | 0.146 | CF transmembrane conductance regulator agonist | 0.146 0.083 DBMET01894 | DBMET01894 | |
| 0.015 | 0.166 | 0.087 | Prostaglandin antagonist | 0.087 0.021 DBMET01895 | DBMET01895 | |
| 0.042 | 0.193 | 0.096 | Polo-like kinase-4 inhibitor | 0.096 0.081 DBMET01892 | DBMET01892 | |
| 0.074 | 0.227 | 0.158 | Protein kinase (CK1) gamma 3 inhibitor | 0.158 0.081 DBMET01894 | DBMET01894 | |
| 0.078 | 0.23 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.099 DBMET01892 | DBMET01892 | |
| 0.02 | 0.173 | 0.048 | Nicotinic receptor alpha4 subunit antagonist | 0.048 0.036 DBMET01892 | DBMET01892 | |
| 0.055 | 0.212 | 0.206 | Lipid peroxidase inhibitor | 0.206 0.039 DBMET01889 0.206 0.039 DBMET01891 | DBMET01891 | |
| 0.008 | 0.169 | 0.025 | Motilin receptor agonist | 0.025 0.013 DBMET01889 0.025 0.013 DBMET01891 | DBMET01891 | |
| 0.01 | 0.172 | 0.021 | Toll-Like receptor 8 agonist | 0.021 0.012 DBMET01894 | DBMET01894 | |
| 0.055 | 0.218 | 0.178 | Protein kinase (CK1) gamma inhibitor | 0.178 0.053 DBMET01894 | DBMET01894 | |
| 0.016 | 0.18 | 0.063 | Sphingosine 1-phosphate receptor agonist | 0.063 0.015 DBMET01895 | DBMET01895 | |
| 0.107 | 0.278 | 0.231 | Superoxide dismutase inhibitor | 0.231 0.088 DBMET01894 0.226 0.093 DBMET01895 | DBMET01894 | |
| 0.04 | 0.211 | 0.106 | MAP kinase 9 inhibitor | 0.106 0.058 DBMET01894 | DBMET01894 | |
| 0.033 | 0.208 | 0.167 | Topoisomerase I inhibitor | 0.167 0.035 DBMET01889 0.167 0.035 DBMET01891 | DBMET01891 | |
| 0.056 | 0.231 | 0.121 | Cytokine production inhibitor | 0.121 0.088 DBMET01894 0.117 0.093 DBMET01895 | DBMET01894 | |
| 0.095 | 0.274 | 0.16 | Phospholipase C inhibitor | 0.146 0.114 DBMET01888 0.146 0.114 DBMET01890 0.149 0.109 DBMET01892 0.16 0.088 DBMET01895 | DBMET01895 | |
| 0.137 | 0.316 | 0.432 | Histamine release inhibitor | 0.432 0.059 DBMET01889 0.432 0.059 DBMET01891 | DBMET01891 | |
| 0.016 | 0.198 | 0.057 | CDK9/cyclin T1 inhibitor | 0.057 0.043 DBMET01894 | DBMET01894 | |
| 0.033 | 0.217 | 0.072 | Glycine receptor antagonist | 0.072 0.071 DBMET01892 | DBMET01892 | |
| 0.023 | 0.208 | 0.067 | Check point kinase 1 inhibitor | 0.06 0.058 DBMET01892 0.067 0.049 DBMET01894 | DBMET01894 | |
| 0.034 | 0.222 | 0.153 | Inducible nitric-oxide synthase inhibitor | 0.153 0.015 DBMET01894 | DBMET01894 | |
| 0.081 | 0.272 | 0.246 | Non-steroidal antiinflammatory agent | 0.246 0.044 DBMET01889 0.246 0.044 DBMET01891 0.159 0.104 DBMET01895 | DBMET01891 | |
| 0.026 | 0.218 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.04 DBMET01895 | DBMET01895 | |
| 0.177 | 0.369 | 0.675 | Antiinflammatory | 0.347 0.175 DBMET01888 0.347 0.175 DBMET01890 0.675 0.036 DBMET01889 0.675 0.036 DBMET01891 0.339 0.181 DBMET01895 | DBMET01891 | |
| 0.022 | 0.215 | 0.074 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.071 0.059 DBMET01892 0.074 0.055 DBMET01894 | DBMET01894 | |
| 0.019 | 0.212 | 0.057 | Purinergic P2X2 antagonist | 0.057 0.054 DBMET01894 | DBMET01894 | |
| 0.036 | 0.234 | 0.105 | MAP kinase 8 inhibitor | 0.105 0.055 DBMET01894 | DBMET01894 | |
| 0.031 | 0.23 | 0.122 | MAO inhibitor | 0.122 0.073 DBMET01894 | DBMET01894 | |
| 0.008 | 0.21 | 0.047 | Sphingosine 1-phosphate receptor 1 agonist | 0.047 0.023 DBMET01895 | DBMET01895 | |
| 0.045 | 0.247 | 0.086 | MAP kinase kinase 1 inhibitor | 0.086 0.076 DBMET01894 | DBMET01894 | |
| 0.033 | 0.235 | 0.129 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.129 0.061 DBMET01894 | DBMET01894 | |
| 0.033 | 0.235 | 0.129 | Abl kinase inhibitor | 0.129 0.061 DBMET01894 | DBMET01894 | |
| 0.013 | 0.216 | 0.037 | Somatostatin 5 agonist | 0.037 0.021 DBMET01894 | DBMET01894 | |
| 0.113 | 0.32 | 0.365 | Immunomodulator | 0.214 0.147 DBMET01888 0.214 0.147 DBMET01890 0.243 0.121 DBMET01893 0.365 0.055 DBMET01889 0.365 0.055 DBMET01891 0.321 0.071 DBMET01894 0.238 0.125 DBMET01895 | DBMET01891 | |
| 0.044 | 0.252 | 0.146 | MAP kinase kinase inhibitor | 0.146 0.054 DBMET01894 | DBMET01894 | |
| 0.046 | 0.257 | 0.106 | Adenylate cyclase inhibitor | 0.094 0.09 DBMET01894 0.106 0.079 DBMET01895 | DBMET01895 | |
| 0.164 | 0.377 | 0.289 | 5 Hydroxytryptamine release inhibitor | 0.289 0.178 DBMET01894 | DBMET01894 | |
| 0.073 | 0.285 | 0.144 | DNA repair enzyme inhibitor | 0.144 0.037 DBMET01889 0.144 0.037 DBMET01891 | DBMET01891 | |
| 0.029 | 0.245 | 0.15 | Cyclin-dependent kinase 5 inhibitor | 0.15 0.041 DBMET01894 | DBMET01894 | |
| 0.034 | 0.252 | 0.162 | DNA intercalator | 0.127 0.053 DBMET01893 0.105 0.068 DBMET01889 0.105 0.068 DBMET01891 0.162 0.038 DBMET01894 | DBMET01894 | |
| 0.023 | 0.243 | 0.094 | MAP kinase 10 inhibitor | 0.094 0.039 DBMET01894 | DBMET01894 | |
| 0.043 | 0.265 | 0.213 | Amylase inhibitor | 0.213 0.04 DBMET01889 0.213 0.04 DBMET01891 | DBMET01891 | |
| 0.037 | 0.26 | 0.176 | Nitric-oxide synthase inhibitor | 0.176 0.014 DBMET01894 | DBMET01894 | |
| 0.071 | 0.294 | 0.207 | Interleukin 6 antagonist | 0.207 0.037 DBMET01889 0.207 0.037 DBMET01891 0.135 0.116 DBMET01894 | DBMET01891 | |
| 0.044 | 0.271 | 0.106 | Protein kinase (CK1) gamma 2 inhibitor | 0.106 0.077 DBMET01894 | DBMET01894 | |
| 0.042 | 0.271 | 0.265 | CDC-like kinase 2 inhibitor | 0.265 0.041 DBMET01894 | DBMET01894 | |
| 0.014 | 0.244 | 0.034 | Glutamate (mGluR4) agonist | 0.034 0.023 DBMET01895 | DBMET01895 | |
| 0.042 | 0.273 | 0.128 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.128 0.107 DBMET01894 | DBMET01894 | |
| 0.045 | 0.277 | 0.113 | Interleukin 5 antagonist | 0.113 0.029 DBMET01895 | DBMET01895 | |
| 0.011 | 0.251 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 DBMET01895 | DBMET01895 | |
| 0.027 | 0.269 | 0.198 | Pim-1 kinase inhibitor | 0.198 0.015 DBMET01894 | DBMET01894 | |
| 0.039 | 0.283 | 0.09 | GABA C receptor rho-1 antagonist | 0.09 0.078 DBMET01894 | DBMET01894 | |
| 0.031 | 0.277 | 0.072 | Sphingosine 1-phosphate receptor antagonist | 0.072 0.065 DBMET01895 | DBMET01895 | |
| 0.064 | 0.311 | 0.321 | Platelet adhesion inhibitor | 0.321 0.027 DBMET01889 0.321 0.027 DBMET01891 | DBMET01891 | |
| 0.016 | 0.268 | 0.068 | Glutamate (mGluR group III) agonist | 0.038 0.037 DBMET01894 0.068 0.016 DBMET01895 | DBMET01895 | |
| 0.003 | 0.265 | 0.036 | Prostaglandin EP2 agonist | 0.036 0.01 DBMET01895 | DBMET01895 | |
| 0.04 | 0.303 | 0.262 | CDC-like kinase 4 inhibitor | 0.262 0.042 DBMET01894 | DBMET01894 | |
| 0.038 | 0.302 | 0.253 | Clk dual-specificity kinase inhibitor | 0.253 0.054 DBMET01894 | DBMET01894 | |
| 0.102 | 0.366 | 0.252 | Vasodilator, coronary | 0.252 0.132 DBMET01889 0.252 0.132 DBMET01891 | DBMET01891 | |
| 0.009 | 0.276 | 0.058 | Thymidylate synthase inhibitor | 0.058 0.019 DBMET01895 | DBMET01895 | |
| 0.069 | 0.336 | 0.247 | Vasodilator | 0.247 0.07 DBMET01889 0.247 0.07 DBMET01891 | DBMET01891 | |
| 0.033 | 0.302 | 0.104 | GABA C receptor antagonist | 0.104 0.072 DBMET01894 | DBMET01894 | |
| 0.112 | 0.384 | 0.362 | Apoptosis antagonist | 0.201 0.178 DBMET01888 0.201 0.178 DBMET01890 0.362 0.05 DBMET01889 0.362 0.05 DBMET01891 | DBMET01891 | |
| 0.069 | 0.345 | 0.152 | Interferon gamma antagonist | 0.152 0.075 DBMET01889 0.152 0.075 DBMET01891 | DBMET01891 | |
| 0.071 | 0.349 | 0.243 | DNA damaging | 0.243 0.084 DBMET01894 | DBMET01894 | |
| 0.049 | 0.329 | 0.087 | T cell inhibitor | 0.087 0.044 DBMET01895 | DBMET01895 | |
| 0.018 | 0.3 | 0.117 | Protein kinase (CK2) inhibitor | 0.117 0.05 DBMET01894 0.089 0.074 DBMET01895 | DBMET01894 | |
| 0.034 | 0.317 | 0.096 | Beta glucuronidase inhibitor | 0.096 0.077 DBMET01889 0.096 0.077 DBMET01891 | DBMET01891 | |
| 0.032 | 0.319 | 0.182 | AMP-activated protein kinase stimulant | 0.182 0.014 DBMET01889 0.182 0.014 DBMET01891 | DBMET01891 | |
| 0.015 | 0.307 | 0.073 | Phenylalanine 4-hydroxylase inhibitor | 0.073 0.043 DBMET01895 | DBMET01895 | |
| 0.123 | 0.418 | 0.623 | Cyclophilin D inhibitor | 0.273 0.188 DBMET01888 0.273 0.188 DBMET01890 0.623 0.024 DBMET01889 0.623 0.024 DBMET01891 0.339 0.131 DBMET01895 | DBMET01891 | |
| 0.05 | 0.35 | 0.216 | Hypolipemic | 0.157 0.13 DBMET01888 0.157 0.13 DBMET01890 0.216 0.084 DBMET01889 0.216 0.084 DBMET01891 | DBMET01891 | |
| 0.017 | 0.319 | 0.138 | Protein kinase (CK2) alpha inhibitor | 0.138 0.05 DBMET01894 0.112 0.067 DBMET01895 | DBMET01894 | |
| 0.009 | 0.313 | 0.047 | Thromboxane antagonist | 0.047 0.045 DBMET01895 | DBMET01895 | |
| 0.026 | 0.336 | 0.101 | ATPase (Vacuolar H+) inhibitor | 0.101 0.038 DBMET01889 0.101 0.038 DBMET01891 | DBMET01891 | |
| 0.024 | 0.339 | 0.086 | Myeloperoxidase inhibitor | 0.086 0.055 DBMET01894 | DBMET01894 | |
| 0.04 | 0.369 | 0.167 | Cell wall synthesis inhibitor | 0.167 0.05 DBMET01889 0.167 0.05 DBMET01891 | DBMET01891 | |
| 0.026 | 0.359 | 0.192 | I kappa B kinase 1 inhibitor | 0.192 0.006 DBMET01894 | DBMET01894 | |
| 0.003 | 0.337 | 0.017 | Prokineticin receptor 1 antagonist | 0.017 0.012 DBMET01894 | DBMET01894 | |
| 0.024 | 0.373 | 0.098 | Bronchodilator | 0.098 0.066 DBMET01893 | DBMET01893 | |
| 0.025 | 0.376 | 0.122 | GABA C receptor agonist | 0.088 0.082 DBMET01894 0.122 0.048 DBMET01895 | DBMET01895 | |
| 0.015 | 0.372 | 0.103 | Protein kinase A inhibitor | 0.103 0.043 DBMET01894 | DBMET01894 | |
| 0.038 | 0.396 | 0.168 | Interleukin 8 antagonist | 0.168 0.024 DBMET01894 0.123 0.058 DBMET01895 | DBMET01894 | |
| 0.049 | 0.411 | 0.195 | Hemostatic | 0.195 0.035 DBMET01889 0.195 0.035 DBMET01891 0.138 0.084 DBMET01895 | DBMET01891 | |
| 0.027 | 0.39 | 0.194 | Cyclin-dependent kinase 7 inhibitor | 0.194 0.036 DBMET01894 | DBMET01894 | |
| 0.034 | 0.399 | 0.151 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.151 0.094 DBMET01894 | DBMET01894 | |
| 0.028 | 0.394 | 0.119 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.119 0.108 DBMET01894 | DBMET01894 | |
| 0.025 | 0.41 | 0.264 | Dyrk kinase inhibitor | 0.264 0.066 DBMET01894 | DBMET01894 | |
| 0.025 | 0.41 | 0.247 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.247 0.069 DBMET01894 | DBMET01894 | |
| 0.025 | 0.41 | 0.095 | Chelator | 0.095 0.085 DBMET01895 | DBMET01895 | |
| 0.057 | 0.444 | 0.155 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.155 0.138 DBMET01894 | DBMET01894 | |
| 0.065 | 0.458 | 0.343 | Cholesterol antagonist | 0.343 0.067 DBMET01889 0.343 0.067 DBMET01891 | DBMET01891 | |
| 0.041 | 0.436 | 0.195 | Interleukin 4 antagonist | 0.195 0.024 DBMET01895 | DBMET01895 | |
| 0.025 | 0.427 | 0.195 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.195 0.081 DBMET01894 | DBMET01894 | |
| 0.021 | 0.435 | 0.175 | Aminoacyl-tRNA synthetase inhibitor | 0.175 0.014 DBMET01894 0.11 0.036 DBMET01895 | DBMET01894 | |
| 0.015 | 0.453 | 0.062 | Heparanase inhibitor | 0.062 0.019 DBMET01889 0.062 0.019 DBMET01891 | DBMET01891 | |
| 0.019 | 0.461 | 0.07 | Parathyroid hormone antagonist | 0.07 0.007 DBMET01894 | DBMET01894 | |
| 0.052 | 0.506 | 0.4 | Antithrombotic | 0.4 0.049 DBMET01889 0.4 0.049 DBMET01891 | DBMET01891 | |
| 0.035 | 0.498 | 0.246 | Nitric oxide antagonist | 0.246 0.053 DBMET01889 0.246 0.053 DBMET01891 | DBMET01891 | |
| 0.014 | 0.478 | 0.085 | Topoisomerase II alpha inhibitor | 0.085 0.05 DBMET01889 0.085 0.05 DBMET01891 | DBMET01891 | |
| 0.046 | 0.512 | 0.349 | Transcription factor NF kappa B inhibitor | 0.349 0.077 DBMET01889 0.349 0.077 DBMET01891 | DBMET01891 | |
| 0.027 | 0.507 | 0.055 | Lipocortins synthesis agonist | 0.055 0.05 DBMET01889 0.055 0.05 DBMET01891 | DBMET01891 | |
| 0.07 | 0.553 | 0.219 | Caspase 3 stimulant | 0.219 0.144 DBMET01889 0.219 0.144 DBMET01891 | DBMET01891 | |
| 0.026 | 0.522 | 0.188 | Platelet antagonist | 0.187 0.111 DBMET01889 0.187 0.111 DBMET01891 0.188 0.111 DBMET01895 | DBMET01895 | |
| 0.019 | 0.524 | 0.22 | Thrombolytic | 0.22 0.043 DBMET01889 0.22 0.043 DBMET01891 0.161 0.073 DBMET01895 | DBMET01891 | |
| 0.047 | 0.565 | 0.52 | Antibacterial | 0.52 0.035 DBMET01889 0.52 0.035 DBMET01891 | DBMET01891 | |
| 0.024 | 0.543 | 0.137 | Cell adhesion inhibitor | 0.137 0.054 DBMET01889 0.137 0.054 DBMET01891 | DBMET01891 | |
| 0.04 | 0.563 | 0.393 | Immunosuppressant | 0.212 0.185 DBMET01888 0.212 0.185 DBMET01890 0.393 0.066 DBMET01889 0.393 0.066 DBMET01891 | DBMET01891 | |
| 0.046 | 0.572 | 0.427 | Hypoglycemic | 0.427 0.024 DBMET01889 0.427 0.024 DBMET01891 | DBMET01891 | |
| 0.022 | 0.551 | 0.321 | Free radical scavenger | 0.321 0.046 DBMET01889 0.321 0.046 DBMET01891 | DBMET01891 | |
| 0.027 | 0.559 | 0.359 | Antioxidant | 0.359 0.044 DBMET01889 0.359 0.044 DBMET01891 | DBMET01891 | |
| 0.075 | 0.61 | 0.132 | CC chemokine 6 receptor antagonist | 0.132 0.064 DBMET01889 0.132 0.064 DBMET01891 | DBMET01891 | |
| 0.011 | 0.555 | 0.062 | Botulinum neurotoxin type A inhibitor | 0.062 0.034 DBMET01894 | DBMET01894 | |
| 0.004 | 0.569 | 0.035 | Protocollagen prolyl hydroxylase inhibitor | 0.035 0.01 DBMET01895 | DBMET01895 | |
| 0.023 | 0.606 | 0.11 | Toll-Like receptor 4 antagonist | 0.11 0.055 DBMET01889 0.11 0.055 DBMET01891 | DBMET01891 | |
| 0.047 | 0.654 | 0.416 | Apoptosis agonist | 0.416 0.106 DBMET01889 0.416 0.106 DBMET01891 | DBMET01891 | |
| 0.004 | 0.632 | 0.066 | Prostaglandin EP2 antagonist | 0.066 0.036 DBMET01895 | DBMET01895 | |
| 0.008 | 0.654 | 0.085 | Protein 50S ribosomal subunit inhibitor | 0.085 0.018 DBMET01889 0.085 0.018 DBMET01891 | DBMET01891 | |
| 0.013 | 0.69 | 0.213 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.213 0.046 DBMET01894 | DBMET01894 | |
| 0.029 | 0.708 | 0.289 | Hepatoprotectant | 0.289 0.033 DBMET01889 0.289 0.033 DBMET01891 | DBMET01891 | |
| 0.058 | 0.755 | 0.33 | Interleukin 2 agonist | 0.21 0.173 DBMET01888 0.21 0.173 DBMET01890 0.33 0.055 DBMET01889 0.33 0.055 DBMET01891 | DBMET01891 | |
| 0.013 | 0.711 | 0.432 | Angiogenesis stimulant | 0.432 0.017 DBMET01889 0.432 0.017 DBMET01891 | DBMET01891 | |
| 0.01 | 0.718 | 0.176 | Immunostimulant | 0.176 0.135 DBMET01889 0.176 0.135 DBMET01891 | DBMET01891 | |
| 0.003 | 0.767 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.027 0.015 DBMET01889 0.027 0.015 DBMET01891 | DBMET01891 | |
| 0.007 | 0.773 | 0.118 | Anticoagulant | 0.118 0.115 DBMET01889 0.118 0.115 DBMET01891 | DBMET01891 | |
| 0.004 | 0.83 | 0.224 | Selectin antagonist | 0.224 0.009 DBMET01889 0.224 0.009 DBMET01891 | DBMET01891 | |
| 0.003 | 0.849 | 0.086 | Antineoplastic antibiotic | 0.086 0.053 DBMET01889 0.086 0.053 DBMET01891 | DBMET01891 | |
| 0.006 | 0.857 | 0.06 | Antibiotic Aminoglycoside-like | 0.06 0.009 DBMET01889 0.06 0.009 DBMET01891 | DBMET01891 | |
| 0.018 | 0.884 | 0.088 | Transcription factor NF kappa B stimulant | 0.088 0.053 DBMET01889 0.088 0.053 DBMET01891 | DBMET01891 | |
| 0.023 | 0.908 | 0.311 | Sodium/bile acid cotransporter inhibitor | 0.311 0.07 DBMET01895 | DBMET01895 | |
| 0.036 | 0.98 | 0.324 | Peptidyltransferase inhibitor | 0.324 0.017 DBMET01889 0.324 0.017 DBMET01891 0.205 0.092 DBMET01895 | DBMET01891 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |